Physicochemical investigation of the solid dispersion systems of etoricoxib with poloxamer 188

Pharmaceutical Development and Technology

Volumn 14, Issue 4, 2009, Pages 373-379

  Karekar, Poonam ^a   Vyas, Vikrant ^a   Shah, Manali ^a   Sancheti, Pankajkumar ^a   Pore, Yogesh ^a  

^a Government College of Pharmacy   (India)

Author keywords

Amorphous; Dissolution; Etoricoxib; Poloxamer; Solid dispersion

Indexed keywords

ETORICOXIB; POLOXAMER;

ARTICLE; CONTROLLED STUDY; DISPERSION; DRUG SOLUBILITY; HYDROGEN BOND; INFRARED SPECTROSCOPY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; X RAY DIFFRACTION;

CHEMISTRY, PHARMACEUTICAL; CRYSTALLIZATION; CYCLOOXYGENASE 2 INHIBITORS; DRUG CARRIERS; HYDROGEN BONDING; POLOXAMER; PYRIDINES; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SULFONES; X-RAY DIFFRACTION;

EID: 70350645485     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.1080/10837450802683974     Document Type: Article

References (43)

1. Amidon GL, Lennernas H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res (1995);12:413-420.
2. Proudfoot S. Factors affecting bioavailability: Factors influencing drug absorption from gastrointestinal tract. In: Aulton ME, editor. Pharmaceutics: The science of dosage form design. Edinburgh: Churchill Livingstone; (1991):135-173.
3. Horter D, Dressman JB. Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Adv Drug Deliv Rev (1997);25:3-14.
4. Kerc J, Srcic S, Kofler B. Alternative solvent-free preparation methods for felodipine surface solid dispersions. Drug Dev Ind Pharm (1998);24:359-363.
5. Agrawal NGB, Porras AG. Dose proportionality of oral etoricoxib, a highly selective cyclooxygenase-2 inhibitor, in healthy volunteers. J Clin Pharmacol (2001);41:1106-1110.
6. Rodrigues AD, Halpin RA, Geer LA. Absorption, metabolism, and excretion of etoricoxib, a potent and selective cyclooxygenase- 2 inhibitor, in healthy male volunteers. Drug Metab Dispos (2003);31:224-232.
7. Cochrane DJ, Jarvis B, Keating GM. Etoricoxib. Drugs (2002);62:2637-2651.
8. Schott H, Kwan LC, Feldman S. The role of surfactant in the release of very slightly soluble drugs from tablets. J Pharm Sci (1982);71:1038-1045.
9. Veiga F, Teixeria-Dias JJC, Kedzeierewicz F, Sousa A, Maincent P. Inclusion complexation of tolbutamide with d£-cyclodextrin and hydroxypropyl-d£-cyclodextrin. Int J Pharm (1996);129:63-71.
10. Vandelli MA, Salvioli G, Mucci A, Panini R, Malmusi L. 2-Hydroxypropyl-?-cyclodextrin complexation with ursodeoxycholic acid. Int J Pharm (1995);118:77-83.
11. Fernandes CM, Vieira MT, Viega FJ. Physicochemical characterization and in vitro dissolution behavior of nicardipine-cyclodextrins inclusion compounds. Eur J Pharm Sci (2002);15:79-88
12. Archontaki HA, Vertzoni MV, Athanassiou-Malaki MH. Study on the inclusion complexes of bromazepam with d£- and d£-hydroxypropyl- cyclodextrins. J Pharm Biomed Anal (2002);28:761-769.
13. Longxiao L, Suyan Z. Preparation and characterization of inclusion complexes of prazosin hydrochloride with d£-cyclodextrin and hydroxypropyl-d£-cyclodextrin. J Pharm Biomed Anal (2006);40:122-127.
14. Henck JO, Griesser UJ, Burger A. Polymorphie von Arzneistoffen Eine wirtschaftliche Herausforderung? Pharm Ind (1997);59:165-169.
15. Hancock BC, Zografi G. Characteristics and significance of the amorphous state in pharmaceutical systems. J Pharm Sci (1997);86:1-12.
16. Chiou WL, Riegelman S. Pharmaceutical applications of solid dispersion systems. J Pharm Sci (1971);60:1281-1302.
17. Christian L, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm (2000);50:47-60.
18. Serajuddin ATM. Solid dispersion of poorly water-soluble drugs: Early promises, subsequent problems, and recent breakthroughs. J Pharm Sci (1999);88:1058-1066.
19. Craig DQM. The mechanisms of drug release from solid dispersions in water-soluble polymers. Int J Pharm (2002);231:131-144.
20. Zajc N, Obreza A, Bele M, Srcic S. Physical properties and dissolution behaviour of nifedipine/mannitol solid dispersions prepared by hot melt method. Int J Pharm (2005);291:51-58.
21. Wang L, Cui FD, Sunada H. Preparation and evaluation of solid dispersions of nitrendipine prepared with fine silica particles using the melt-mixing method. Chem Pharm Bull (2006);54:37-43.
22. Tantishaiyakul V, Kaewnopparat N, Ingkatawornwong S. Properties of solid dispersions of piroxicam in polyvinylpyrrolidone. Int J Pharm (1999);181:143-151.
23. Weuts I, Kempen D, Verreck G, Decorte A, Heymans K, Peeters J, Brewster M, Mooter GV. Study of the physicochemical properties and stability of solid dispersions of loperamide and PEG 6000 prepared by spray drying. Eur J Pharm Biopharm (2005);59:119-126.
24. Adel El-Egakey M, Soliva M, Speiser P. Hot extruded dosage forms. Pharm Acta Helv (1971);46:31-52.
25. Dastmalchi S, Garjani A, Maleki N, Sheikhee G, Baghchevan V, Jafari-Azad P, Valizadeh H, Barzegar-Jalali M. Enhancing dissolution, serum concentrations and hypoglycemic effect of glibenclamide using solvent deposition technique. J Pharm Pharm Sci (2005);8:175-181.
26. Kim EJ, Chun MK, Jang JS. Preparation of a solid dispersion of felodipine using a solvent wetting method. Eur J Pharm Biopharm (2006);64:200-205.
27. Moneghini M, Bellich B, Baxa P, Princivalle F. Microwave generated solid dispersions containing Ibuprofen. Int J Pharm (2008);361:125-130.
28. Newa M, Bhandari KH, Li DX, Kwon TH, Kim JA, Yoo BK, Woo JS, Lyoo WS, Yong CS, Choi HG. Preparation, characterization and in vivo evaluation of ibuprofen binary solid dispersions with poloxamer 188. Int J Pharm (2007);343:228-237. (Pubitemid 47321028)
29. Singhare DS, Khan S, Yeole PG. Poloxamers: Promising block co-polymers in drug delivery. Indian J Pharm Sci (2005);67:523-531.
30. Higuchi T, Connors KA. Phase-solubility techniques. Adv Anal Chem Instr (1965);4:117-212.
31. Ford JL. The current status of solid dispersions. Pharm Acta Helv (1986);61:69-88.
32. Ryan JA. Compressed pellet x-ray diffraction monitoring for optimisation of crystallinity in lyophilised solids: Imipenem: cilastatin sodium case. J Pharm Sci (1986);75:805-807.
33. Mooter G, Augustijns P, Blaton N, Kinget R. Physico-chemical characterization of solid dispersions of temazepam with polyethylene glycol 6000 and PVP K30. Int J Pharm (1998);164:67-80.
34. Ruan LP, Yu BY, Fu GM, Zhu D. Improving the solubility of ampelopsin by solid dispersions and inclusion complexes. J Pharm Biomed Anal (2005);38:457-464.
35. Passerini N, Gonzalez-Rodriguez ML, Cavallari C, Rodriguez L, Albertini B. Preparation and characterisation of ibuprofenpoloxamer 188 granules obtained by melt granulation. Eur J Pharm Sci (2002);15:71-78.
36. Khan KA. The concept of dissolution efficiency. J Pharm Pharmacol (1975);27:48-49.
37. Corrigan OI, Holohan EM, Reilly MR. Physicochemical properties of indomethacin and related compound co-spray dried with polyvinyl pyrrolidone. Drug Dev Ind Pharm (1985);11:677-695.
38. Suhagia BN, Patel HM, Shah SA, Rathod I, Parmar VK. Preparation and characterization of etoricoxib-polyethylene glycol 4000 plus polyvinylpyrrolidone K30 solid dispersions. Acta Pharm (2006);56:285-298.
39. Chauhan B, Shimpi S, Paradkar A. Preparation and characterization of etoricoxib solid dispersions using lipid carriers by spray drying technique. AAPS PharmSciTech (2005);6(3):50.
40. Shimpi SL, Chauhan B, Mahadik KR, Paradkar A. Stabilization and improved in vivo performance of amorphous etoricoxib using Gelucire 50/13. Pharm Res (2005);22:1727-1734.
41. Shimpi S, Mahadik K, Takada K, Paradkar A. Application of polyglycolized glycerides in protection of amorphous form of etoricoxib during compression. Chem Pharm Bull (2007);55:1448-1451.
42. Geneidi AS, Ali AA, Salama RB. Solid dispersions of nitrofurantoin, ethotoin and coumarin with polyethylene glycol 6000 and other coprecipitates with povidone 25000. J Pharm Sci (1978);67:114-116.
43. Save T, Venkitachalam P. Studies on solid dispersions of nifedipine. Drug Dev Ind Pharm (1992);18:1663-1679.